Clinical Trials Browser

Terminated × Oligodendroglioma × antineoplaston AS 2-1 × Clear all

NCT00003472 2018-03-21

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Phase 2 Terminated

13 enrolled 6 charts

Oligodendroglioma, Recurrence